secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartCore Enterprises, Inc. (HTCR)
CIK:        0001892322
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001493152-24-038054
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SBC Medical Group begins trading on Nasdaq; HeartCore guides Q3 rev $19-23M, net profit $4-8M
--------------------------------------------------------------------------------

- Go IPO client SBC Medical Group commenced trading on Nasdaq Global Market under symbol 'SBC'.
- HeartCore generated $17.9M total revenue from SBC deal; $17M recognized in Q3 2024.
- HeartCore holds $8M worth of SBC stock after IPO.
- Q3 2024 guidance: revenue $19M-$23M, net profit $4M-$8M.
- Sold $9M of warrants to a Japanese financial institution in Q1 2024; net sales $5.64M after referral fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1892322/000149315224038054/0001493152-24-038054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1892322/000149315224038054/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer